The Japanese guidance for the prevention and treatment of pediatric atopic dermatitis was created in accordance with the Guidelines for the management of Atopic Dermatitis 2024 (ADGL), with the aim of producing an easy-to-use guide for primary care settings, where clinicians frequently manage atopic dermatitis that develops in early infancy.

The diagnostic and treatment algorithm is basically consistent with the ADGL, with an additional pathway included for referring cases whose remission induction or maintenance proves challenging to specialists. Differential diagnoses and potential complications are based on the diagnostic criteria established by the Japanese Dermatological Association, taking into account diseases that are prevalent or characteristic in pediatric populations. For cases requiring early diagnosis, the UK Working Party's diagnostic criteria are also referenced.

Remission induction involves the continuous application of appropriately potent topical anti-inflammatory agents. Maintenance therapy is tailored to either proactive or reactive approaches, depending on the patient's response. In refractory cases, combined systemic therapy may be considered, with the primary objective of achieving treatment goals: absence of symptoms or only mild symptoms that do not interfere with daily functioning and require minimal ongoing medication.